Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and ...
Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and ...
Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and ...
More than 50 drugs which include paracetamol, Calcium, vitamin D3 supplements, anti-diabetes pills, and high blood pressure ...
CDSCO declared more than 50 drugs, including calcium and vitamin D3 supplements, high blood pressure medicines, and ...
The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard ...
India's drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, ...
The Central Drugs Standards Control Organization (CDSCO) raised serious safety concerns by declaring over 50 medications as ...
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor ...